Bead-based ELISA for validation of ovarian cancer early detection markers
about
Beyond CA125: the coming of age of ovarian cancer biomarkersComparison of breast cancer to healthy control tissue discovers novel markers with potential for prognosis and early detectionEffects of blood collection conditions on ovarian cancer serum markers.A mouse to human search for plasma proteome changes associated with pancreatic tumor development.Systematic evaluation of candidate blood markers for detecting ovarian cancer.Assessing lead time of selected ovarian cancer biomarkers: a nested case-control studyUse of a Symptom Index, CA125, and HE4 to predict ovarian cancer.CA125 in ovarian cancerAntifouling surface layers for improved signal-to-noise of particle-based immunoassays.HE4 and CA125 as a diagnostic test in ovarian cancer: prospective validation of the Risk of Ovarian Malignancy Algorithm.Potential markers for detection and monitoring of ovarian cancer.Synthesis, characterization, and directional binding of anisotropic biohybrid microparticles for multiplexed biosensing.Method for generation of in vivo biotinylated recombinant antibodies by yeast mating.Evaluation of ovarian cancer biomarkers HE4 and CA-125 in women presenting with a suspicious cystic ovarian mass.Evaluation of ovarian cancer remission markers HE4, MMP7 and Mesothelin by comparison to the established marker CA125Evaluating Serum Markers for Hormone Receptor-Negative Breast Cancer.N-linked glycan structures and their expressions change in the blood sera of ovarian cancer patients.N-glycan MALDI Imaging Mass Spectrometry on Formalin-Fixed Paraffin-Embedded Tissue Enables the Delineation of Ovarian Cancer Tissues.HE4 protein and SMRP: Potential novel biomarkers in ovarian cancer detection.Profiling lipid-protein interactions using nonquenched fluorescent liposomal nanovesicles and proteome microarraysBiomarker method validation in anticancer drug developmentRecent technical strategies to identify diagnostic biomarkers for ovarian cancer.HE4 (WFDC2) Promotes Tumor Growth in Endometrial Cancer Cell LinesProgrammable bio-nano-chip systems for serum CA125 quantification: toward ovarian cancer diagnostics at the point-of-care.Effects of personal characteristics on serum CA125, mesothelin, and HE4 levels in healthy postmenopausal women at high-risk for ovarian cancer.A serum based analysis of ovarian epithelial tumorigenesisInfluence of ovarian cancer risk status on the diagnostic performance of the serum biomarkers mesothelin, HE4, and CA125.Combining a symptoms index with CA 125 to improve detection of ovarian cancer.Phase II trial of single agent cetuximab in patients with persistent or recurrent epithelial ovarian or primary peritoneal carcinoma with the potential for dose escalation to rashUse of yeast-secreted in vivo biotinylated recombinant antibodies (Biobodies) in bead-based ELISA.HE4 transcription- and splice variants-specific expression in endometrial cancer and correlation with patient survival.Identification of novel candidate plasma metabolite biomarkers for distinguishing serous ovarian carcinoma and benign serous ovarian tumorsTumor markers for early detection of ovarian cancer.Multiplexed protein detection by proximity ligation for cancer biomarker validation.Tumor associated antigens or anti-TAA autoantibodies as biomarkers in the diagnosis of ovarian cancer: a systematic review with meta-analysis.CMOS biosensors for in vitro diagnosis - transducing mechanisms and applications.The role of HE4 in ovarian cancer: inhibiting tumour cell proliferation and metastasis.Selenium-Binding Protein 1 (SBP1) autoantibodies in ovarian disorders and ovarian cancer.Splice variant HE4-V3 expression is associated with favorable prognosis in pulmonary adenocarcinoma.Serum soluble mesothelin-related peptide (SMRP): a potential diagnostic and monitoring marker for epithelial ovarian cancer.
P2860
Q24651567-00F46C08-6488-4E40-A23D-E311D016FB8DQ28748985-F28F13F1-570D-46AC-A569-7FF729AD8E75Q33308744-51CF275D-E987-47AF-B0DB-DC06767F9E47Q33343004-AD48C733-0818-4DD5-96BC-C0070344212DQ33350146-CBBF5C5B-CC2F-4E4B-9633-FC9B79604E15Q33574039-C69EE57C-CE43-4912-B389-A00155079470Q33653799-66ADC31B-2A5C-4F57-B35F-6FD74E3D4976Q33859857-E59F2AE6-FEB0-4E4D-9094-B4A92EA89B87Q33939569-5F56E682-52A6-4F55-B44B-06BBA64F595DQ34621826-EBF1933D-B39D-4419-8969-49C2743CD03AQ34960174-40C13F63-AE67-487F-9E39-F8C195D902A1Q35084237-AA5B776B-A47A-41F3-8A8B-445DBD8D9B6AQ35613964-CDFE406A-F6D8-48BD-A314-9C72F3EB50B5Q35663640-E06BE43D-8470-42F3-9296-4858351BEB1FQ35830931-D5EBEF61-352B-42C3-B6C1-CD2278380A7CQ35840714-9093FA97-2326-4546-81E3-78D58C335E01Q35874750-4BF2A63D-02D2-49D0-BE40-BCBFF85E29D6Q36076879-3181C431-F8CA-4E9D-B1CD-5588EAFE63A5Q36226142-16128C45-1547-4D35-AB37-756DA6B05B17Q36386960-4A7B8454-7D38-43E9-8990-1C95828BF4F5Q36484621-00AAD299-2FD7-4637-9C64-8743909F44B3Q36731399-EA249D0E-7544-4108-826B-EC96833F5D24Q36790307-7C92E384-24E2-42AD-8147-D46EB82C98B9Q36915914-EDCD49C2-0AAC-4C75-B142-4107C7721653Q37076713-2393847E-EAF3-448C-82DB-E1FDBC9BE150Q37133800-B001618F-CC5E-4B2E-89C2-83357ABBC375Q37270601-B0DA4AC1-890D-48BE-949D-DE0F58E5FFABQ37324647-9E308E5B-8BCF-476A-A3E0-760E9FAD6FDEQ37340624-8C115447-8C03-4E39-936F-8540BC7075F1Q37348306-13FD4541-30B6-42FB-AD9D-9819094824ADQ37375504-A5D08857-D0B7-4ABD-8033-F3AD3A39F3E6Q37643626-F0DE3FCF-7138-4A14-90F8-0D80303A64D1Q37789033-1B7EEAC7-D2EE-468C-B886-7D5DF5F00759Q38398465-BA630700-DCC6-4593-9647-C2B32A56F356Q38470014-08693F36-5613-4DE5-B7D0-7D6723D9FB11Q38974546-13D29199-44A2-4B53-923C-D2D64C1D533CQ39437253-B4DE74D7-131D-48D0-B014-F3E537469547Q40428099-C82DA192-70D1-40D1-A995-0A66D118C16DQ43728520-02AC1036-94D9-4FD7-AC9C-2D2DCDBF7730Q43799326-70A728B8-EF71-4055-B6EE-4A4924CF0E73
P2860
Bead-based ELISA for validation of ovarian cancer early detection markers
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on April 2006
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Bead-based ELISA for validation of ovarian cancer early detection markers
@en
Bead-based ELISA for validation of ovarian cancer early detection markers.
@nl
type
label
Bead-based ELISA for validation of ovarian cancer early detection markers
@en
Bead-based ELISA for validation of ovarian cancer early detection markers.
@nl
prefLabel
Bead-based ELISA for validation of ovarian cancer early detection markers
@en
Bead-based ELISA for validation of ovarian cancer early detection markers.
@nl
P2093
P2860
P1476
Bead-based ELISA for validation of ovarian cancer early detection markers
@en
P2093
Alicia Sato
Charles W Drescher
Garnet L Anderson
Kathy C O'Briant
Meghan Crawford
Nancy Kiviat
Nicole Urban
P2860
P304
P356
10.1158/1078-0432.CCR-05-2007
P407
P433
P577
2006-04-01T00:00:00Z